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The staphylococcal msr(A) gene, coding for a macrolide efflux protein, was identified in three new gram-
positive genera and one gram-negative genus. These msr(A) genes shared 99 to 100% identity with each other
and the staphylococcal gene. This study demonstrates that the msr(A) gene has a wider host range than
previously reported.
Macrolide resistance is typically due to the acquisition of genes
coding for rRNA methylases, macrolide efflux proteins, and/or
inactivation enzymes (10, 12, 15) (http://faculty.washington.edu
/marilynr/). The use of macrolide-lincosamide-streptogramin
(MLS) antibiotics has increased over the last 20 years and has
been correlated with an increase in bacterial resistance to
macrolides, due primarily to acquisition of a new gene(s), usu-
ally on mobile elements (12, 15). Sixty-four different acquired
MLS resistance genes have been identified, with 14 of these
genes found in more than two genera and 50 identified in one
or two genera. The msr(A) gene codes for an ATP transporter
that transports erythromycin and streptogramin B from the cell
using energy from ATP hydrolysis and has been identified only
in Staphylococcus spp. (9, 12–15).
Recently another gene, msr(D), with similarities to the msr(A)
gene has been found downstream of another macrolide efflux
gene, mef(A), and both genes have a wide host range encompass-
ing both gram-negative and gram-positive genera (1, 7, 10) (http:
//faculty.washington.edu/marilynr/). Therefore, we hypothesized
that the msr(A) gene may also have a wider host range. To test
this hypothesis, 1,125 Streptococcus spp., 226 Staphylococcus spp.,
193 Enterococcus spp., and 100 gram-negative isolates from oral
samples, as well as 566 Staphylococcus spp., 160Enterococcus spp.,
and 100 gram-negative isolates from urine samples (3, 7, 8), were
screened using DNA-DNA hybridization (4, 7). The isolates were
randomly selected commensal bacteria collected between 1997
and 2004 from healthy children in Lisbon, Portugal, in a random-
ized study aimed at assessing the safety of low-level mercury
exposure from dental amalgam restorations (3, 7, 8). The isolates
were previously identified using biochemical methods (3, 5). We
also included 17 macrolide-resistant (Emr) Corynebacterium spp.
isolated from skin cultures in 1997 from patients attending an
acne clinic at the University of Leeds, United Kingdom (2).
Forty-two Staphylococcus spp., 2 Staphylococcus aureus spp.,
5 Enterococcus spp., 10 Streptococcus spp., 7 Pseudomonas spp.,
and 1 Corynebacterium sp. were positive for the msr(A) gene.
All the positive Enterococcus spp., Streptococcus spp., Coryne-
bacterium sp., Pseudomonas spp., and a selected number of the
Staphylococcus spp. were used as templates in an msr(A) PCR
assay with S. aureus RN4220 carrying a cloned msr(A) gene as
the positive control (Table 1) (13, 14). All of the isolates tested
produced PCR products of the correct size which hybridized
with an internal probe. Thus, the msr(A)-positive staphylococci
represented 5.6% of the isolates, the one msr(A)-positive
Corynebacterium sp. represented 5.9% of the small number of
Emr Corynebacterium spp., and the msr(A)-positive Enterococ-
cus spp. and Streptococcus spp. represented 1.7% and 0.9% of
the isolates, respectively. We also identified 7 (10%) msr(A)-
positive Pseudomonas spp., including 2 Pseudomonas aerugi-
nosa spp., out of 69 urine isolates examined. A similar number
of oral Pseudomonas spp. from the same population were also
screened, but none were positive for the msr(A) gene.
We had previously examined these isolates for other MLS
genes (2, 3, 7) and found that 57% of the Staphylococcus spp.
carried at least one erm gene, which codes for an rRNA meth-
ylase enzyme that confers resistance to macrolides, lincos-
amides, and streptogramin B (2, 3, 12, 15), and that all of the
other msr(A)-positive isolates carried at least one erm gene
and/or mef(A) genes. The seven Pseudomonas spp. carried
from one to five other MLS genes (Table 2).
To determine whether these genes were closely related to
the Staphylococcus msr(A) genes, one msr(A)-positive isolate
from each of the four genera, Corynebacterium, Enterococcus,
Streptococcus, and Pseudomonas, was selected, and the com-
plete structural msr(A) gene was sequenced using PCR assays
and primers indicated in Table 1. The PCR products were
confirmed using an internal 32P-labeled probe, cloned into the
pCRT7/NT-TOPO vector (Invitrogen, Carlsbad, CA), and
transformed into Escherichia coli TOP10 following the manu-
facturer’s instructions. All sequencing was carried out at the
University of Washington, Department of Biochemistry Se-
quencing Facility, as previously described (7, 8). The msr(A)
genes from the Corynebacterium sp. (AY591760), Enterococcus
sp. (DQ068449), and Streptococcus sp. (DQ131177) were in-
distinguishable at the DNA and amino acid levels from each
other and the Staphylococcus msr(A) gene (GenBank acces-
sion no. AB016613). The Pseudomonas msr(A) gene
(DQ068450) shared 99% identity at the DNA and amino acid
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level with this Staphylococcus msr(A) gene and had two amino
acid changes at positions 59 and 430 (see Fig. S1 in the sup-
plemental material). The variability found in the Pseudomonas
msr(A) gene is within the range (98 to 100%) found
among different Staphylococcus msr(A) genes (http://faculty
.washington.edu/marilynr/).
The upstream region of the msr(A) genes in staphylococci is
thought to be involved with regulation. Therefore, it was of in-
terest to determine whether this upstream region was also present
upstream of the Pseudomonas msr(A) structural gene. A PCR
assay, consisting of the primer msrA-F3 located 328 bp upstream
of the ribosome binding site and the primer msrAF-REV located
544 bp downstream from the start codon of the msr(A) structural
gene, was used to generate the sequences upstream of the start
codon of the Pseudomonas msr(A) gene, which were indistin-
guishable from the upstream sequences of the Staphylococcus
msr(A) gene (see Fig. S2 in the supplemental material). The
upstream and complete msr(A) gene sequences are at GenBank,
accession no. DQ068450.
A second Pseudomonas sp. msr(A) gene has now been par-
tially sequenced and has the same high level of homology with
the Staphylococcus msr(A) gene as the first gene sequence. We
have also recently verified the presence of an msr(A) gene in
an Enterobacter isolate from this same collection, suggesting
that other gram-negative genera may also carry this gene. The
Enterobacter isolate has an erythromycin MIC of 128 g/ml
using standard CLSI (formerly NCCLS) methods (6) and does
not carry any of the other known gram-negative MLS resis-
tance genes (7).
There have been 64 different acquired MLS genes iden-
tified in bacteria; however, only 17 (27%) of these genes are
found in more than a single genus (http://faculty.washington
.edu/marilynr/). As illustrated in this and other studies (3, 7, 10,
11), if MLS genes are screened in new genera, they are often
found. Thus, screening for the presence of the msr(A) gene
should be considered when examining the distributions of MLS
genes in either gram-positive or gram-negative isolates.
This study was supported by grant U01 DE-1189 and contract N01
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